batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Dizal's birelentinib remains a question mark 29 August 2025 BeOne sees a first route to market for sonrotoclax 29 August 2025 Lepu sees pancreatic cancer promise for tissue factor 28 August 2025 Nykode’s Regeneron deal runs into trouble 28 August 2025 Wugen’s T-cell fundraiser 28 August 2025 Novocure’s Lunar eclipse 28 August 2025 Lilly's dual Nectin-4 effort back on track 25 August 2025 Bladder cancer next for Datroway 22 August 2025 Load More